sq-18506 has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueding, E; Dolan, PM; Dunsford, HA; Keysser, CH; Seed, JL | 1 |
| Bueding, E; Dolan, PM; Dunsford, HA; Seed, JL | 1 |
2 other study(ies) available for sq-18506 and Experimental Neoplasms
| Article | Year |
|---|---|
Carcinogenicity of the antischistosomal nitrofuran trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole.
Topics: 5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole; Aging; Animals; Carcinogens; Dose-Response Relationship, Drug; Female; Male; Mice; Neoplasms, Experimental; Nitrofurans; Schistosoma mansoni; Schistosomiasis | 1984 |
Effects of multiple putative anticarcinogens on the carcinogenicity of trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole.
Topics: 5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole; Adenocarcinoma; Animals; Antineoplastic Agents; Antioxidants; Carcinogens; Carcinoma, Squamous Cell; Female; Leukemia, Experimental; Lung Neoplasms; Lymphoma; Mice; Neoplasms, Experimental; Nitrofurans; Sarcoma, Experimental | 1984 |